Literature DB >> 15358104

Thioredoxin-1 mediates osteoclast stimulation by reactive oxygen species.

Jennifer Lean1, Barrie Kirstein, Zoë Urry, Timothy Chambers, Karen Fuller.   

Abstract

We found that the antioxidant protein thioredoxin-1 (Trx) is more highly expressed in osteoclasts than in macrophages. Moreover, transfection of RAW 264.7 (RAW) cells with a Trx-expression construct resulted in a dramatic increase in their capacity for osteoclast formation. In contrast, Trx-expression was suppressed and osteoclast formation was abrogated by transfection with the antioxidant proteins glutathione peroxidase-1 (Gpx) or peroxiredoxin-1 (Prx). These divergent effects suggest that Trx augments osteoclast formation through some special function. It is known that Trx enhances the binding of several transcription factors to DNA. We found that AP-1, NFkappaB, and NFAT-reporter gene expression was enhanced more greatly by RANKL in RAW cells transfected with the Trx-expression construct. Thus, oxidants stimulate osteoclastic differentiation by induction of Trx-expression, which augments the DNA binding of transcription factors essential for osteoclastic differentiation. Conversely, antioxidants, including Gpx and Prx, suppress Trx-expression and thereby osteoclastic differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358104     DOI: 10.1016/j.bbrc.2004.07.035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  The immune system and bone.

Authors:  Roberto Pacifici
Journal:  Arch Biochem Biophys       Date:  2010-06-17       Impact factor: 4.013

2.  Enhanced osteoclastogenesis by mitochondrial retrograde signaling through transcriptional activation of the cathepsin K gene.

Authors:  Manti Guha; Satish Srinivasan; Alexander Koenigstein; Mone Zaidi; Narayan G Avadhani
Journal:  Ann N Y Acad Sci       Date:  2015-03-18       Impact factor: 5.691

Review 3.  Estrogen deficiency and bone loss: an inflammatory tale.

Authors:  M Neale Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  Ascorbate synthesis pathway: dual role of ascorbate in bone homeostasis.

Authors:  Kenneth H Gabbay; Kurt M Bohren; Roy Morello; Terry Bertin; Jeff Liu; Peter Vogel
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

5.  Suppression effect of N-acetylcysteine on bone loss in ovariectomized mice.

Authors:  Xun Zhou; Zhengbo Wang; Yihong Ni; Yue Yu; Guantong Wang; Lulu Chen
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

6.  Hypoxia-mediated mitochondrial stress in RAW264.7 cells induces osteoclast-like TRAP-positive cells.

Authors:  Satish Srinivasan; Narayan G Avadhani
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

7.  Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation.

Authors:  Francesco Grassi; Gianluca Tell; Michaela Robbie-Ryan; Yuhao Gao; Masakazu Terauchi; Xiaoying Yang; Milena Romanello; Dean P Jones; M Neale Weitzmann; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

Review 8.  The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis.

Authors:  Wacili Da; Lin Tao; Yue Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 5.555

9.  Vitamin E as an Antiosteoporotic Agent via Receptor Activator of Nuclear Factor Kappa-B Ligand Signaling Disruption: Current Evidence and Other Potential Research Areas.

Authors:  Kok-Yong Chin; Soelaiman Ima-Nirwana
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-02       Impact factor: 2.629

10.  Oxidative stress and bone resorption interplay as a possible trigger for postmenopausal osteoporosis.

Authors:  Carlo Cervellati; Gloria Bonaccorsi; Eleonora Cremonini; Arianna Romani; Enrica Fila; Maria Cristina Castaldini; Stefania Ferrazzini; Melchiorre Giganti; Leo Massari
Journal:  Biomed Res Int       Date:  2014-01-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.